Lupus erythematosus/lichen planus overlap syndrome: successful treatment with acitretin

被引:14
|
作者
Lospinoso, D. J. [1 ]
Fernelius, C. [2 ]
Edhegard, K. D. [3 ]
Finger, D. R. [4 ]
Arora, N. S. [1 ]
机构
[1] Tripler Army Med Ctr, Dermatol Serv, Honolulu, HI 96859 USA
[2] Tripler Army Med Ctr, Dept Pathol, Honolulu, HI 96859 USA
[3] Walter Reed Natl Mil Med Ctr, Dept Dermatol, Bethesda, MD USA
[4] Tripler Army Med Ctr, Rheumatol Serv, Honolulu, HI 96859 USA
关键词
Lupus erythematosus; lichen planus; lupus erythematosus; lichen planus overlap syndrome; acitretin; direct immunofluorescence staining; LICHEN-PLANUS;
D O I
10.1177/0961203313492243
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lupus erythematosus/lichen planus overlap syndrome is a rare disorder combining the clinical, histological and immunopathological features of both lupus erythematosus (LE) and lichen planus (LP). Cutaneous lesions mostly affect the distal arms, legs, face and trunk. Palmoplantar involvement is felt to be characteristic of this condition. Plaques are often painful, centrally atrophic, bluish-red to hypopigmented in color, large, and scaly. On biopsy of clinically ambiguous lesions, histopathological features of one or both processes can be found, obscuring the diagnosis and complicating prognosis and treatment. Thus, direct immunofluorescence has become an essential tool in helping to diagnose this condition. In this report we describe the unique clinical and immunohistopathological manifestations of lupus erythematosus/lichen planus overlap syndrome along with a successful response to treatment with acitretin.
引用
收藏
页码:851 / 854
页数:4
相关论文
共 50 条